Hypertension myocardial fibrosis
- PMID: 17617768
- PMCID: PMC8109858
- DOI: 10.1111/j.1524-6175.2007.07274.x
Hypertension myocardial fibrosis
Comment on
-
Mechanisms of cardiac fibrosis in hypertension.J Clin Hypertens (Greenwich). 2007 Jul;9(7):546-50. doi: 10.1111/j.1524-6175.2007.06626.x. J Clin Hypertens (Greenwich). 2007. PMID: 17617765 Free PMC article. Review.
Similar articles
-
Mechanisms of cardiac fibrosis in hypertension.J Clin Hypertens (Greenwich). 2007 Jul;9(7):546-50. doi: 10.1111/j.1524-6175.2007.06626.x. J Clin Hypertens (Greenwich). 2007. PMID: 17617765 Free PMC article. Review.
-
Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.Circulation. 2004 Sep 7;110(10):1263-8. doi: 10.1161/01.CIR.0000140973.60992.9A. Epub 2004 Aug 16. Circulation. 2004. PMID: 15313958
-
Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists.Am J Cardiol. 1995 Nov 2;76(13):24D-30D. doi: 10.1016/s0002-9149(99)80488-3. Am J Cardiol. 1995. PMID: 7495214 Review.
-
Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension.Circulation. 2001 Jul 17;104(3):346-51. doi: 10.1161/01.cir.104.3.346. Circulation. 2001. PMID: 11457756
-
Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.Herz. 2003 Dec;28(8):744-53. doi: 10.1007/s00059-003-2524-6. Herz. 2003. PMID: 14689110
Cited by
-
Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode.BMC Complement Altern Med. 2016 Feb 6;16:56. doi: 10.1186/s12906-016-1030-3. BMC Complement Altern Med. 2016. PMID: 26852136 Free PMC article.
References
-
- Whaley‐Connell A, Govindararajan G, Habibi J, et al. Angiotensin‐II mediated oxidative stress promotes myocardial tissue remodeling in the transgenic TG (mRen2) 27 Ren2 rat. Am J Physiol Endocrinol Metab. 2007; Epub ahead of print. - PubMed
-
- Habibi J, Whaley‐Connell A, Qazi MA, et al. Rosuvastatin, a 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren 2 transgenic rats. Endocrinology. 2007;148(5):2181–2188. - PubMed
-
- Funder JW. Mineralocorticoid receptors and cardiovascular damage: its not just aldosterone. Hypertension. 2006;47(4):634–635. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical